Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,477 | 123,665 | 120,542 | 192,412 | 83,000 |
| Marketable Securities | 206,812 | 203,235 | 193,759 | 161,868 | 190,476 |
| Receivables | 25,150 | 1,566 | 2,638 | 7,077 | 3,996 |
| Other current assets | 2,878 | 2,792 | 1,871 | 2,778 | 1,823 |
| TOTAL | $341,522 | $340,736 | $327,687 | $371,818 | $285,508 |
| Non-Current Assets | |||||
| PPE Net | 2,064 | 1,798 | 1,723 | 1,718 | 1,432 |
| Investments And Advances | 0 | 0 | 38,169 | 26,122 | 6,254 |
| Other Non-Current Assets | 4,710 | 5,161 | 5,596 | 4,574 | 4,878 |
| TOTAL | $6,774 | $6,959 | $45,488 | $32,414 | $12,564 |
| Total Assets | $348,296 | $347,695 | $373,175 | $404,232 | $298,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,539 | 2,499 | 1,827 | 19,301 | 9,555 |
| Accrued Expenses | 32,874 | 37,716 | 33,061 | 20,096 | 17,680 |
| TOTAL | $43,456 | $44,016 | $39,156 | $42,973 | $34,515 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 768 | 1,601 | 2,241 | 2,009 | 5,768 |
| Other Non-Current Liabilities | 3,062 | 3,658 | 4,359 | 3,812 | 4,223 |
| TOTAL | $3,062 | $3,658 | $4,359 | $3,812 | $4,223 |
| Total Liabilities | $46,518 | $47,674 | $43,515 | $46,785 | $38,738 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,656 | 48,414 | 47,728 | 47,551 | 43,945 |
| Retained earnings | -430,292 | -409,362 | -372,455 | -338,651 | -307,809 |
| Other shareholders' equity | -472 | -299 | -204 | -59 | -33 |
| TOTAL | $301,778 | $300,021 | $329,660 | $357,447 | $259,334 |
| Total Liabilities And Equity | $348,296 | $347,695 | $373,175 | $404,232 | $298,072 |